JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C100623200 on November 5, 2001

J. Biol. Chem., Vol. 277, Issue 1, 5-8, January 4, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/1/5    most recent
C100623200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Snyder, P. M.
Right arrow Articles by Thomas, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Snyder, P. M.
Right arrow Articles by Thomas, B. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ACCELERATED PUBLICATION
Serum and Glucocorticoid-regulated Kinase Modulates Nedd4-2-mediated Inhibition of the Epithelial Na+ Channel*

Peter M. SnyderDagger, Diane R. Olson, and Brittany C. Thomas

From the Department of Internal Medicine and Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, Iowa 52242

Received for publication, October 28, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The epithelial Na+ channel (ENaC) forms the pathway for Na+ absorption across epithelia, including the kidney collecting duct, where it plays a critical role in Na+ homeostasis and blood pressure control. Na+ absorption is regulated in part by mechanisms that control the expression of ENaC at the apical cell surface. Nedd4 family members (e.g. Nedd4, Nedd4-2) bind to the channel and decrease its surface expression by catalyzing its ubiquitination and degradation. Conversely, serum and glucocorticoid-regulated kinase (SGK), a downstream mediator of aldosterone, increases the expression of ENaC at the cell surface. Here we show that SGK and human Nedd4-2 (hNedd4-2) converge in a common pathway to regulate epithelial Na+ absorption. Consistent with this model, we found that SGK bound to hNedd4-2 and hNedd4. A PY motif in SGK mediated the interaction and was required for SGK to stimulate ENaC. SGK phosphorylated hNedd4-2 (but not hNedd4), altering hNedd4-2 function; phosphorylation reduced the binding of hNedd4-2 to alpha ENaC, and hence, the hNedd4-2-mediated inhibition of Na+ absorption. These data suggest that SGK regulates epithelial Na+ absorption in part by modulating the function of hNedd4-2.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The epithelial Na+ channel (ENaC)1 forms the pathway for Na+ absorption across a variety of epithelia, including the kidney collecting duct, airway, and distal colon (reviewed in Refs. 1 and 2). Three homologous subunits (alpha -, beta -, and gamma ENaC) form the channel complex (3, 4). Dominant gain of function mutations in ENaC cause Liddle's syndrome, an inherited form of hypertension (5). Conversely, loss of function mutations cause salt wasting and hypotension (pseudohypoaldosteronism type I) (5). Thus, the regulation of ENaC is critical for the maintenance of Na+ homeostasis and for blood pressure control.

In the kidney collecting duct, Na+ absorption must vary over a wide range in response to conditions of Na+ depletion or Na+ excess. This occurs in large part by mechanisms that modulate the expression of ENaC at the apical cell surface (reviewed in Ref. 6). For example, the Nedd4 family of ubiquitin protein-ligases (including Nedd4 and Nedd4-2) reduce ENaC surface expression (7-9). They contain multiple WW domains that bind to PY motifs in the C termini of alpha -, beta -, and gamma ENaC (10-12). This interaction facilitates the ubiquitination of ENaC, catalyzed by a ubiquitin ligase domain at the C terminus of Nedd4 family members (7, 8). Ubiquitination reduces ENaC at the cell surface by increasing the rate of channel degradation (7). Liddle's syndrome is caused by defects in this regulatory pathway; mutations in the ENaC PY motifs disrupt their interaction with Nedd4 family members, resulting in increased expression of ENaC at the cell surface, and hence, excessive Na+ absorption (10, 13, 14). Thus, the Nedd4 family of proteins is critically important in reducing Na+ absorption.

Conversely, the renin-angiotensin-aldosterone pathway increases renal Na+ absorption, in part by increasing the expression of ENaC at the cell surface (15). This pathway plays a key role in responding to Na+ depletion and hypovolemia. Moreover, disruption of this pathway underlies several acquired and genetic disorders of blood pressure control, including primary aldosteronism and glucocorticoid-remediable aldosteronism (5). An important downstream mediator of aldosterone is serum and glucocorticoid-regulated kinase (SGK), (16, 17). SGK transcription is induced by aldosterone over a very rapid time course (30-60 min) (16, 17), and it is post-translationally activated in response to insulin and other stimuli by phosphorylation through the phosphoinositide 3-kinase pathway (18). Thus, it has been proposed that SGK integrates a variety of signals that modulate renal Na+ absorption (19). SGK increases the expression of ENaC at the cell surface (20), but little is known about the mechanisms involved. Previous work reported that SGK phosphorylates Ser/Thr residues within the sequence RXRXXS/T (18, 21). However, ENaC subunits are not phosphorylated by SGK (19). Thus, it seems likely that SGK phosphorylates one or more proteins involved in controlling ENaC surface expression, although such SGK substrates have not yet been identified.

Two observations suggest the possibility that the Nedd4 family and SGK might converge in a common pathway to regulate ENaC surface expression. First, SGK contains a PY motif (see Fig. 1A), suggesting that it might bind directly to WW domains in Nedd4 or Nedd4-2. Second, Nedd4-2 (but not hNedd4) contains three sequences that fit the consensus for phosphorylation by SGK, suggesting it might be a SGK substrate. The goal of this work was to test the hypothesis that SGK modulates ENaC surface expression in part through the phosphorylation of Nedd4-2.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

DNA Constructs-- hNedd4 was cloned as described previously (12). hNedd4-2 and human SGK were cloned by PCR of cDNA reverse transcribed from kidney poly(A)+ RNA (CLONTECH). Mutations were created using QuikChange Kit (Stratagene) and each cDNA was sequenced in the University of Iowa DNA Sequencing Core. Human alpha -, beta -, and gamma ENaC in pMT3 or pcDNA3 were cloned as described previously (4). The PY motifs of each subunit were mutated to PLP motifs (P7LP6) to disrupt binding to the hNedd4-2 WW domains. A FLAG epitope (DYKDDDDK) was introduced at the C terminus of SGK to allow immunodetection. This epitope did not alter ENaC stimulation by SGK.

Binding of SGK to hNedd4 and hNedd4-2-- cDNA encoding wild-type or mutant (Y298A or K127M) SGK or GFP (negative control) was expressed in COS-7 cells by electroporation, as described previously (13). The cells were lysed and protein solubilized in TBS (150 mM NaCl, 50 mM Tris, pH 7.4) containing 1% Triton X-100 and protease inhibitors (0.4 mM phenylmethylsulfonyl fluoride, 20 µg/ml aprotonin, 20 µg/ml leupeptin, and 10 µg/ml pepstatin A). SGK was immunoprecipitated from 100 µl of lysate (1 µg/µl total protein) with anti-FLAG M2 monoclonal antibody (1:1000, Eastman Kodak Co.) and protein A beads (Pierce). hNedd4-2 and hNedd4 (20 µl) were generated and [35S]methionine-labeled by in vitro transcription and translation (TNT kit, Promega) then incubated with immunoprecipitated SGK or SGKY298A (or GFP) for 16 h. The beads were washed three times with TBS/1% Triton X-100, separated by SDS-PAGE, and imaged by fluorography.

To detect total SGK, SGKY298A, or SGKK127M, 30 µg of lysate was separated by SDS-PAGE, transferred to a polyvinylidene difluoride membrane, and blocked overnight with 5% dry milk in TBS containing 0.1% Triton X-100. The membrane was incubated for 2 h with anti-FLAG M2 antibody (1:1000), 1 h with horseradish peroxidase-coupled sheep anti-mouse IgG (1:50,000, Amersham Biosciences, Inc.), and imaged by chemiluminescence (ECL Plus, Amersham Biosciences, Inc.).

Expression and Electrophysiology in FRT Epithelia-- FRT cells were grown on permeable filter supports as described (22). One day after seeding, cells were cotransfected with alpha -, beta -, and gamma ENaC (0.07 µg each) and hNedd4-2, SGK, or GFP as a negative control (0.02-0.8 µg using TFX 50 (22)). The total DNA was held constant by varying the ratio of hNedd4-2 or SGK to GFP. Expression of GFP did not alter ENaC Na+ currents.

Na+ transport was measured 2-3 days after transfection in modified Ussing chambers (Warner Instrument Corporation). The apical and basolateral surfaces were bathed in 135 mM NaCl, 1.2 mM CaCl2, 1.2 mM MgCl2, 2.4 mM K2HPO4, 0.6 mM KH2PO4, 10 mM dextrose, 10 mM HEPES, pH 7.4, at 37 °C and bubbled with O2. Amiloride-sensitive short-circuit current was determined as the difference in current with and without amiloride (10 µM) in the apical bathing solution.

SGK Phosphorylation of hNedd4-2 and hNedd4-- cDNAs encoding hNedd4-2, hNedd4, or GFP (negative control) were expressed in COS-7 cells, solubilized in TBS containing 1% Triton X-100, and 250 µg of the lysates were immunoprecipitated with sheep anti-WW1 (hNedd4-2 and GFP) or sheep anti-WW2 (hNedd4) (1:100) (12). Immunoprecipitated protein was suspended in 15 mM MgCl2, 100 µM ATP, 20 mM MOPS, pH 7.2, 25 mM beta -glycerol phosphate, 5 mM EGTA, 1 mM Na+ orthovanadate, 1 mM dithiothreitol, 2 µM protein kinase A inhibitor peptide (Sigma), and 10 µCi of [gamma -32P]ATP. The samples were incubated with or without activated SGK (25 ng of SGK1 Delta 1-60, S422D, Upstate Biotechnology) for 60 min at 30 °C. The beads were washed three times with 500 µl of TBS containing 1% Triton X-100 and proteins detected by SDS-PAGE and fluorography. To detect total hNedd4-2 and hNedd4 protein, COS-7 cells were labeled for 1 h with [35S]methionine, and cell lysates were immunoprecipitated as described above.

Binding of hNedd4-2 to ENaC-- hNedd4-2, hNedd4, or GFP expressed in COS-7 cells were immunoprecipitated, incubated with or without activated SGK (1 mM cold ATP substituted for [gamma -32P]ATP), and incubated for 16 h with 20 µl of alpha ENaC (transcribed, translated, and [35S]methionine-labeled in vitro). The beads were washed three times with TBS 1% Triton X-100, separated by SDS-PAGE, and imaged by fluorography.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

SGK Binds to hNedd4-2 and hNedd4-- The PY motif (PPXY) is a sequence that mediates protein interactions through its binding to type I WW domains (23). SGK contains a sequence that fits the PY motif consensus (PPFY, amino acids 295-298, Fig. 1A). Members of the Nedd4 family contain multiple WW domains, which bind to PY motifs in ENaC. We tested the hypothesis that their WW domains might also bind to SGK. SGK (containing a FLAG epitope at the C terminus) was expressed in COS-7 cells. We detected SGK protein by Western blot (using anti-FLAG M2 antibody) in cells expressing SGK, but not in cells expressing GFP (Fig. 1B). To test for interactions, we incubated immunoprecipitated SGK with hNedd4-2 or hNedd4 (generated and [35S]methionine-labeled by in vitro translation). Both hNedd4-2 and hNedd4 bound to SGK, but not to immunoprecipitated protein from cells expressing GFP (Fig. 1C). The PY motif of SGK mediated these interactions; mutation of a critical residue within the motif (Y298A) abolished SGK binding to hNedd4-2 and hNedd4 (Fig. 1C). This did not result from decreased protein production; the mutant and wild-type constructs generated similar amounts of SGK protein (Fig. 1B).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 1.   Binding of SGK to hNedd4 and hNedd4-2. A, schematic of SGK, including PY motif (PPFY, amino acids 295-298). B, Western blot of SGK, SGKY298A, or GFP expressed in COS-7 cells using anti-FLAG M2 antibody (1:1000). C, autoradiogram of hNedd4-2 and hNedd4 (translated and [35S]methionine-labeled in vitro) bound to immunoprecipitated SGK, SGKY298A, or GFP. D, amiloride-sensitive short-circuit currents for alpha -, beta -, and gamma ENaC (0.07 µg each) transiently expressed in FRT cells with wild-type (wt) or mutant SGK (as indicated) or GFP as a negative control (0.8 µg) (mean ± S.E., n = 14-22). Asterisks indicate p < 0.0001 versus GFP. E, Western blot of SGK, SGKK127M, or GFP expressed in COS-7 cells.

To investigate the functional role of this interaction, we asked whether the SGK PY motif was required to stimulate ENaC. Expression of alpha -, beta -, and gamma ENaC in FRT epithelial cells generated transepithelial short-circuit Na+ currents that were blocked by amiloride (22). Coexpression of ENaC with SGK increased Na+ current 2.7-fold (compared with ENaC expressed with GFP) (Fig. 1D). In contrast, SGKY298A did not stimulate ENaC (Fig. 1D), suggesting that the SGK PY motif is required for stimulation.

SGK Phosphorylates hNedd4-2-- We tested whether SGK kinase activity is required for it to stimulate ENaC in epithelia. In a previous study, mutation of a residue in the ATP binding site (SGKK127M) abolished the ability of SGK to phosphorylate a peptide substrate (18). We found that this mutation prevented SGK from stimulating ENaC expressed in FRT cells (Fig. 1D), but it did not alter levels of SGK protein (Fig. 1E). This suggests that SGK stimulates ENaC by phosphorylating one or more substrates.

SGK phosphorylates serine or threonine residues in the context of the sequence RXRXXS/T (18, 21). Interestingly, hNedd4-2 contains three sequences that fit this consensus (Ser221, Thr246, and Ser327), but they are not conserved in hNedd4 (Fig. 2A). We therefore tested the hypothesis that hNedd4-2 is a substrate for SGK phosphorylation. hNedd4-2, hNedd4, or GFP (negative control) were expressed in COS-7 cells, immunoprecipitated, and incubated with [gamma -32P]ATP with or without an activated form of SGK (Delta 1-60, S422D). We found that SGK phosphorylated hNedd4-2 but not hNedd4 (Fig. 2B). As a control for expression, we labeled cells with [35S]methionine and immunoprecipitated with antibodies against the WW domains. Bands of the appropriate size were detected in cells transfected with hNedd4-2 and hNedd4, but not in cells transfected with GFP (Fig. 2C).


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 2.   Phosphorylation of hNedd4-2 by SGK. A, schematic of hNedd4-2, including the three potential SGK phosphorylation sites (arrowheads), and lineup of hNedd4-2 and hNedd4 in the indicated segment is shown, and the potential SGK phosphorylation sites and WW domain 2 are boxed. B, autoradiogram of hNedd4-2, hNedd4, and GFP incubated with or without activated SGK (Delta 1-60, S422D) in the presence of [gamma -32P]ATP. Data are representative of three experiments. C, immunoprecipitation of hNedd4-2, hNedd4, or GFP expressed in COS-7 cells and labeled for 1 h with [35S]methionine.

SGK Modulates the Function of hNedd4-2-- We tested the hypothesis that phosphorylation alters hNedd4-2 function. ENaC was coexpressed with SGK or GFP (negative control) in FRT cells, along with increasing amounts of hNedd4-2 cDNA. When ENaC was expressed with GFP, hNedd4-2 decreased Na+ current in a dose-dependent manner (Fig. 3A). In contrast, hNedd4-2 reduced current to a lesser extent when expressed with SGK (Fig. 3A). However, a kinase inactive mutant (SGKK127M) did not decrease inhibition (Fig. 3A), suggesting that phosphorylation was required. Thus, SGK-mediated phosphorylation modulates hNedd4-2 function, decreasing its ability to inhibit ENaC.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   SGK modulates hNedd4-2 binding and function. A, amiloride-sensitive short-circuit Na+ current (relative to 0 µg of hNedd4-2) in FRT cells expressing ENaC (0.07 µg of each subunit), SGK (wild-type or SGKK127M, 0.6 µg), and hNedd4-2 (0-0.2 µg). Total cDNA was held constant using GFP cDNA (mean ± S.E., n = 9-15). Asterisks indicate p < 0.02 versus SGKK127M. B, autoradiogram of alpha ENaC (translated and [35S]methionine-labeled in vitro) bound to immunoprecipitated hNedd4-2, hNedd4, or GFP. The hNedd4 proteins and GFP were treated or not treated with SGK (as indicated) prior to binding to alpha ENaC. Data are representative of three experiments. C, percent stimulation of amiloride-sensitive short-circuit Na+ current when alpha -, beta -, and gamma ENaC (0.07 µg each) were expressed in FRT cells with SGK (compared with GFP, 0.8 µg) (mean ± S.E., n = 20-22). Asterisk indicates p < 0.0001 versus wild-type ENaC. The three ENaC subunits were wild-type or contained mutations in the PY motifs, as indicated.

Phosphorylation Alters hNedd4-2 Binding to ENaC-- For hNedd4-2 and hNedd4 to inhibit Na+ current, their WW domains must bind to PY motifs in ENaC (7-9). Interestingly, the SGK consensus sites are located between the WW domains of hNedd4-2, suggesting that phosphorylation might alter its binding to ENaC. To test this hypothesis, we immunoprecipitated hNedd4-2 or hNedd4 from COS-7 cells, followed by incubation with one of the ENaC subunits (alpha ENaC, translated in vitro and labeled with [35S]methionine). We chose to use the alpha  subunit, since previous work suggested that the three ENaC subunits are equivalent in their binding to WW domains (9, 11, 12, 24). alpha ENaC bound to hNedd4-2 and hNedd4, but not to immunoprecipitated lysates from cells expressing GFP (Fig. 3B). Phosphorylation of hNedd4-2 by SGK decreased the binding of hNedd4-2 to alpha ENaC (Fig. 3B). In contrast, SGK caused minimal change in the binding of hNedd4 to alpha ENaC (Fig. 3B), consistent with our finding that SGK did not phosphorylate hNedd4.

The data suggest that SGK might increase Na+ current in part by decreasing the binding of hNedd4-2 to ENaC. Such a mechanism should therefore be disrupted by mutation of the ENaC PY motifs, which are required for this interaction. To test this hypothesis, we expressed ENaC (wild-type or PY motif mutations) with SGK (or GFP as negative control) in FRT cells and measured amiloride-sensitive short-circuit Na+ currents. SGK increased Na+ current in cells expressing wild-type ENaC (167%) but not when the PY motifs were mutated in alpha -, beta -, and gamma ENaC (Fig. 3C). Thus, in epithelial cells, stimulation by SGK was dependent on the PY motifs of ENaC.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The regulation of ENaC is critically important to maintain Na+ homeostasis. Disruption of this regulation causes genetic and acquired forms of hypertension and hypotension (5). Two important regulators of ENaC are aldosterone and its downstream mediator SGK, and the Nedd4 family of ubiquitin protein ligases, which modulate ENaC surface expression in a reciprocal manner. Our data suggest that these two pathways intersect, regulating ENaC in part through a common pathway.

The data support a model in which SGK regulates Na+ absorption in part by modulating the inhibition of ENaC by hNedd4-2 (Fig. 4). Under basal conditions (low aldosterone), hNedd4-2 is unphosphorylated and represses epithelial Na+ transport; its WW domains bind to ENaC PY motifs, resulting in ubiquitination, endocytosis, and degradation of the channel (Fig. 4, left panel). As a result, hNedd4-2 decreases Na+ current by reducing the expression of ENaC at the cell surface. In response to salt deprivation or in pathological states, aldosterone releases this repression of Na+ absorption. Aldosterone stimulates the transcription of SGK (16, 17), which binds to hNedd4-2 and phosphorylates one or more Ser/Thr consensus sites (Fig. 4, right panel). The binding of SGK to hNedd4-2 appears to be essential, since mutation of the SGK PY motif prevented it from stimulating ENaC. Phosphorylation of hNedd4-2 reduces its binding to ENaC, resulting in increased ENaC at the cell surface, and hence, increased Na+ absorption.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   Model for modulation of hNedd4-2 by SGK. hNedd4-2 binds and ubiquitinates ENaC, targeting the channel for endocytosis and degradation (left panel). Aldosterone increases transcription of SGK, which binds to hNedd4-2 (via SGK PY motif, right panel). SGK phosphorylates hNedd4-2, which decreases its binding to ENaC. As a result, hNedd4-2-mediated degradation of ENaC is reduced, leading to increased expression of ENaC at the cell surface.

How might phosphorylation alter the binding of hNedd4-2 to ENaC? Although we do not yet have direct evidence to support a mechanism, it is interesting to note that the potential phosphorylation sites are located in segments between WW domains. For example, Ser221 and Thr246 are located between WW domains 1 and 2, and Ser327 is located between WW domains 2 and 3 (Fig. 2A). Perhaps phosphorylation induces a conformational change in hNedd4-2, altering the accessibility of the WW domains to bind ENaC. Interestingly, GenBankTM contains at least three different hNedd4-2 splice forms, differing in the number of potential SGK phosphorylation sites. The splice form we studied (Nedd4La, also known as Nedd18) corresponds most closely to mouse Nedd4-2 and has three potential phosphorylation sites. A second form, KIAA0439, lacks a 20-amino acid segment between WW domains 1 and 2, which deletes one of the SGK sites (Thr246). A third variant, DKFZp234p2422, lacks the second and third SGK sites, as well as WW domain 2. Importantly, each splice form appears to be expressed in collecting duct epithelia,2 and all three inhibit ENaC (Fig. 3 and Ref. 25). Thus, it seems possible that the splice forms could be differentially phosphorylated, and thus, differentially regulated by SGK. Alternatively, perhaps only the site present in all three forms is phosphorylated (Ser221).

What is the function of the interaction between SGK and hNedd4-2? A recurring theme is that many signaling molecules assemble into complexes to target their activity to specific substrates. Interactions between signaling molecules can occur through adapter proteins, such as protein kinase A anchoring proteins (26). Interactions can also be direct; phosphorylation of the N-methyl-D-aspartic acid receptor by calcium- and calmodulin-dependent protein kinase II is mediated by a direct interaction (27). Thus, perhaps SGK binding targets its kinase activity to hNedd4-2. Binding can also be required to activate a kinase; N-methyl-D-aspartic acid receptor binding activates calcium- and calmodulin-dependent protein kinase II, a mechanism thought to be important for learning and memory (28). Similarly, SGK might be activated through its binding to hNedd4-2.

In addition to hNedd4-2, the function of ENaC may also be regulated by other ubiquitin protein-ligases. Nedd4 is expressed in the renal collecting duct (29) and inhibits ENaC (7, 8, 30). However, SGK consensus phosphorylation sites are not present in Nedd4, suggesting that SGK does not modulate the activity of this ubiquitin protein-ligase. Consistent with such a hypothesis, we found that SGK did not phosphorylate hNedd4 or alter its binding to alpha ENaC. This raises several possibilities. Perhaps Nedd4 inhibits ENaC in a constitutive manner. More likely, the inhibition of ENaC by Nedd4 might be regulated by different mechanisms. In this regard, it has been reported that cytosolic Ca2+ alters the localization of Nedd4, resulting in its translocation to the cell surface (31). Alternatively, Nedd4 might be phosphorylated by a different kinase or might be transcriptionally regulated. Finally, it is possible that Nedd4 does not regulate Na+ transport in epithelia, despite its ability to inhibit ENaC expressed in heterologous cells.

Could SGK modulate ENaC function by additional mechanisms? Several observations raise this possibility. For example, it is possible that the SGK PY motif competes with ENaC for binding to the WW domains of hNedd4-2 (or other ubiquitin protein-ligases). In this way, SGK could increase Na+ current by directly blocking the binding of hNedd4-2 to ENaC. However, competition for hNedd4-2 binding does not appear to be the sole mechanism, since SGK kinase activity was also required for ENaC stimulation and for SGK to modulate hNedd4-2 function. In addition, SGK might stimulate ENaC through mechanisms independent of hNedd4-2. In support of this possibility, in Xenopus oocytes, mutation of the ENaC PY motifs did not prevent SGK from increasing Na+ current (20), in contrast to our data in epithelia. It was also reported that SGK could bind directly to the C terminus of alpha - and beta ENaC (19). However, SGK did not phosphorylate ENaC, and the functional role and the sequences that mediate this interaction are not yet known.

Our data suggest that aldosterone, SGK, and hNedd4-2 converge into a common pathway to regulate Na+ absorption. Within this pathway, hNedd4-2 and related members of the Nedd4 family might form a central point of convergence to regulate ENaC surface expression, and hence, to maintain Na+ homeostasis.

    ACKNOWLEDGEMENTS

We thank Anikó Náray-Fejes-Tóth, Michael Welsh, John Stokes, Christie Thomas, Christopher Benson, and our other laboratory colleagues for helpful discussions and Sarah Hestekin, Elizabeth Wood, and Alex Kipp for technical assistance.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger P. M.Supported by the Roy J. Carver Charitable Trust and NHLBI Grants HL58812, HL03575, HL55006, and HL61781 and NIDDK Grant DK52617, National Institutes of Health. To whom correspondence should be addressed: 371 EMRB, Dept. of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA 52242. E-mail: psnyder@ blue.weeg.uiowa.edu.

Published, JBC Papers in Press, November 5, 2001, DOI 10.1074/jbc.C100623200

2 C. P. Thomas, personal communication.

    ABBREVIATIONS

The abbreviations used are: ENaC, epithelial Na+ channel; hNedd4, human Nedd4; hNedd4-2, human Nedd4-2; SGK, serum and glucocorticoid-regulated kinase; FRT, Fischer rat thyroid; GFP, green fluorescent protein; MOPS, 4-morpholinepropanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Garty, H., and Palmer, L. G. (1997) Physiol. Rev. 77, 359-396
2. Stokes, J. B. (1999) Kidney Int. 56, 2318-2333
3. Canessa, C. M., Schild, L., Buell, G., Thorens, B., Gautschi, I., Horisberger, J. D., and Rossier, B. C. (1994) Nature 367, 463-467
4. McDonald, F. J., Price, M. P., Snyder, P. M., and Welsh, M. J. (1995) Am. J. Physiol. 268, C1157-C1163
5. Lifton, R. P. (1996) Science 272, 676-680
6. Snyder, P. M. (2001) Endocr. Rev., in press
7. Goulet, C. C., Volk, K. A., Adams, C. M., Prince, L. S., Stokes, J. B., and Snyder, P. M. (1998) J. Biol. Chem. 273, 30012-30017
8. Abriel, H., Loffing, J., Rebhun, J. F., Pratt, J. H., Schild, L., Horisberger, J. D., Rotin, D., and Staub, O. (1999) J. Clin. Invest. 103, 667-673
9. Kamynina, E., Debonneville, C., Bens, M., Vandewalle, A., and Staub, O. (2001) FASEB J. 15, 204-214
10. Staub, O., Dho, S., Henry, P., Correa, J., Ishikawa, T., McGlade, J., and Rotin, D. (1996) EMBO J. 15, 2371-2380
11. Farr, T. J., Coddington-Lawson, S. J., Snyder, P. M., and McDonald, F. J. (2000) Biochem. J. 345, 503-509
12. Snyder, P. M., Olson, D. R., McDonald, F. J., and Bucher, D. B. (2001) J. Biol. Chem. 276, 28321-28326
13. Snyder, P. M., Price, M. P., McDonald, F. J., Adams, C. M., Volk, K. A., Zeiher, B. G., Stokes, J. B., and Welsh, M. J. (1995) Cell 83, 969-978
14. Schild, L., Lu, Y., Gautschi, I., Schneeberger, E., Lifton, R. P., and Rossier, B. C. (1996) EMBO J. 15, 2381-2387
15. Masilamani, S., Kim, G. H., Mitchell, C., Wade, J. B., and Knepper, M. A. (1999) J. Clin. Invest. 104, R19-R23
16. Chen, S. Y., Bhargava, A., Mastroberardino, L., Meijer, O. C., Wang, J., Buse, P., Firestone, G. L., Verrey, F., and Pearce, D. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 2514-2519
17. Naray-Fejes-Toth, A., Canessa, C., Cleaveland, E. S., Aldrich, G., and Fejes-Toth, G. (1999) J. Biol. Chem. 274, 16973-16978
18. Park, J., Leong, M. L., Buse, P., Maiyar, A. C., Firestone, G. L., and Hemmings, B. A. (1999) EMBO J. 18, 3024-3033
19. Wang, J., Barbry, P., Maiyar, A. C., Rozansky, D. J., Bhargava, A., Leong, M., Firestone, G. L., and Pearce, D. (2001) Am. J. Physiol. Renal Physiol. 280, F303-F313
20. Alvarez de la Rosa, D., Zhang, P., Naray-Fejes-Toth, A., Fejes-Toth, G., and Canessa, C. M. (1999) J. Biol. Chem. 274, 37834-37839
21. Kobayashi, T., Deak, M., Morrice, N., and Cohen, P. (1999) Biochem. J. 344, 189-197
22. Snyder, P. M. (2000) J. Clin. Invest. 105, 45-53
23. Espanel, X., and Sudol, M. (1999) J. Biol. Chem. 274, 17284-17289
24. Harvey, K. F., Dinudom, A., Cook, D. I., and Kumar, S. (2001) J. Biol. Chem. 276, 8597-8601
25. Kamynina, E., Tauxe, C., and Staub, O. (2001) Am. J. Physiol. Renal Physiol. 281, F469-F477
26. Diviani, D., and Scott, J. D. (2001) J. Cell Sci. 114, 1431-1437
27. Leonard, A. S., Lim, I. A., Hemsworth, D. E., Horne, M. C., and Hell, J. W. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 3239-3244
28. Bayer, K. U., De, Koninck, P., Leonard, A. S., Hell, J. W., and Schulman, H. (2001) Nature 411, 801-805
29. Staub, O., Yeger, H., Plant, P. J., Kim, H., Ernst, S. A., and Rotin, D. (1997) Am. J. Physiol. 272, C1871-C1880
30. Dinudom, A., Harvey, K. F., Komwatana, P., Young, J. A., Kumar, S., and Cook, D. I. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 7169-7173
31. Plant, P. J., Yeger, H., Staub, O., Howard, P., and Rotin, D. (1997) J. Biol. Chem. 272, 32329-32336


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
F. Schuetz, S. Kumar, P. Poronnik, and D. J. Adams
Regulation of the voltage-gated K+ channels KCNQ2/3 and KCNQ3/5 by serum- and glucocorticoid-regulated kinase-1
Am J Physiol Cell Physiol, July 1, 2008; 295(1): C73 - C80.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Fejes-Toth, G. Frindt, A. Naray-Fejes-Toth, and L. G. Palmer
Epithelial Na+ channel activation and processing in mice lacking SGK1
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1298 - F1305.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. J. McDonald
A new SGK1 knockout mouse
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1296 - F1297.
[Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
G. Frindt, Z. Ergonul, and L. G. Palmer
Surface Expression of Epithelial Na Channel Protein in Rat Kidney
J. Gen. Physiol., May 26, 2008; 131(6): 617 - 627.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Bachhuber, J. Almaca, F. Aldehni, A. Mehta, M. D. Amaral, R. Schreiber, and K. Kunzelmann
Regulation of the Epithelial Na+ Channel by the Protein Kinase CK2
J. Biol. Chem., May 9, 2008; 283(19): 13225 - 13232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. S. Raikwar and C. P. Thomas
Nedd4-2 isoforms ubiquitinate individual epithelial sodium channel subunits and reduce surface expression and function of the epithelial sodium channel
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1157 - F1165.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
V. McEneaney, B. J. Harvey, and W. Thomas
Aldosterone Regulates Rapid Trafficking of Epithelial Sodium Channel Subunits in Renal Cortical Collecting Duct Cells via Protein Kinase D Activation
Mol. Endocrinol., April 1, 2008; 22(4): 881 - 892.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. M. C. Connell, S. M. MacKenzie, E. M. Freel, R. Fraser, and E. Davies
A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function
Endocr. Rev., April 1, 2008; 29(2): 133 - 154.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Kabra, K. K. Knight, R. Zhou, and P. M. Snyder
Nedd4-2 Induces Endocytosis and Degradation of Proteolytically Cleaved Epithelial Na+ Channels
J. Biol. Chem., March 7, 2008; 283(10): 6033 - 6039.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Bertog, J. E. Cuffe, S. Pradervand, E. Hummler, A. Hartner, M. Porst, K. F. Hilgers, B. C. Rossier, and C. Korbmacher
Aldosterone responsiveness of the epithelial sodium channel (ENaC) in colon is increased in a mouse model for Liddle's syndrome
J. Physiol., January 15, 2008; 586(2): 459 - 475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Taruno, N. Niisato, and Y. Marunaka
Intracellular calcium plays a role as the second messenger of hypotonic stress in gene regulation of SGK1 and ENaC in renal epithelial A6 cells
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F177 - F186.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Weixel, R. S. Edinger, L. Kester, C. J. Guerriero, H. Wang, L. Fang, T. R. Kleyman, P. A. Welling, O. A. Weisz, and J. P. Johnson
Phosphatidylinositol 4-Phosphate 5-Kinase Reduces Cell Surface Expression of the Epithelial Sodium Channel (ENaC) in Cultured Collecting Duct Cells
J. Biol. Chem., December 14, 2007; 282(50): 36534 - 36542.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
B. Zhao, R. Lehr, A. M. Smallwood, T. F. Ho, K. Maley, T. Randall, M. S. Head, K. K. Koretke, and C. G. Schnackenberg
Crystal structure of the kinase domain of serum and glucocorticoid-regulated kinase 1 in complex with AMP PNP
Protein Sci., December 1, 2007; 16(12): 2761 - 2769.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I.-H. Lee, A. Dinudom, A. Sanchez-Perez, S. Kumar, and D. I. Cook
Akt Mediates the Effect of Insulin on Epithelial Sodium Channels by Inhibiting Nedd4-2
J. Biol. Chem., October 12, 2007; 282(41): 29866 - 29873.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. Li, S. Koshy, and H. G. Folkesson
Involvement of {alpha}ENaC and Nedd4-2 in the conversion from lung fluid secretion to fluid absorption at birth in the rat as assayed by RNA interference analysis
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L1069 - L1078.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. O. Wielputz, I.-H. Lee, A. Dinudom, S. Boulkroun, N. Farman, D. I. Cook, C. Korbmacher, and R. Rauh
(NDRG2) Stimulates Amiloride-sensitive Na+ Currents in Xenopus laevis Oocytes and Fisher Rat Thyroid Cells
J. Biol. Chem., September 21, 2007; 282(38): 28264 - 28273.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Yan, L. Spruce, M. M. Rosenblatt, T. R. Kleyman, and R. C. Rubenstein
Intracellular trafficking of a polymorphism in the COOH terminus of the {alpha}-subunit of the human epithelial sodium channel is modulated by casein kinase 1
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F868 - F876.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. A. Martel, D. Michael, G. Fejes-Toth, and A. Naray-Fejes-Toth
Melanophilin, a novel aldosterone-induced gene in mouse cortical collecting duct cells
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F904 - F913.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Zhou, S. V. Patel, and P. M. Snyder
Nedd4-2 Catalyzes Ubiquitination and Degradation of Cell Surface ENaC
J. Biol. Chem., July 13, 2007; 282(28): 20207 - 20212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. C. Pao, J. A. McCormick, H. Li, J. Siu, C. Govaerts, V. Bhalla, R. Soundararajan, and D. Pearce
NH2 terminus of serum and glucocorticoid-regulated kinase 1 binds to phosphoinositides and is essential for isoform-specific physiological functions
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1741 - F1750.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. R. Quesnell, X. Han, and B. D. Schultz
Glucocorticoids stimulate ENaC upregulation in bovine mammary epithelium
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1739 - C1745.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Fakitsas, G. Adam, D. Daidie, M. X. van Bemmelen, F. Fouladkou, A. Patrignani, U. Wagner, R. Warth, S. M.R. Camargo, O. Staub, et al.
Early Aldosterone-Induced Gene Product Regulates the Epithelial Sodium Channel by Deubiquitylation
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1084 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Y. Huang, K. M. Boini, H. Osswald, B. Friedrich, F. Artunc, S. Ullrich, J. Rajamanickam, M. Palmada, P. Wulff, D. Kuhl, et al.
Resistance of mice lacking the serum- and glucocorticoid-inducible kinase SGK1 against salt-sensitive hypertension induced by a high-fat diet
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1264 - F1273.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. Lang, C. Bohmer, M. Palmada, G. Seebohm, N. Strutz-Seebohm, and V. Vallon
(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms.
Physiol Rev, October 1, 2006; 86(4): 1151 - 1178.
[Abstract] [Full Text] [PDF]